CAS RN: 26586-20-9
3-Chloro-4-morpholinobenzoic Acid
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250321 |
1g / 5g |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 1g, 5g, 10g, 25g, 0.25g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 26586-20-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Shanghai |
Inquiry |
| 5g |
>97% |
5
In Stock
|
Shenzhen |
Inquiry |
| 10g |
>97% |
4
In Stock
|
Shenzhen |
Inquiry |
| 25g |
>97% |
4
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
26586-20-9 / 3-chloro-4-morpholin-4-ylbenzoic acid
Standard CAS: 26586-20-9
Multi CAS: No
Basic Information
CAS
26586-20-9
Multi CAS
No
Molecular Formula
C11H12ClNO3
Molecular Weight
241.670000
Exact Mass
241.050571
SMILES
C1COCCN1C2=C(C=C(C=C2)C(=O)O)Cl
InChI
InChI=1S/C11H12ClNO3/c12-9-7-8(11(14)15)1-2-10(9)13-3-5-16-6-4-13/h1-2,7H,3-6H2,(H,14,15)
InChIKey
GZDHVZCNDDAJPE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
6
Fraction Csp3
0.36
Rotatable bonds
2
H-bond acceptors
3
H-bond donors
1
Molar refractivity
61.44
TPSA
49.77
LogP / Solubility
WLOGP
1.87
MLOGP
1.65
XLogP3
1.8
Consensus LogP
1.77
Log S (ESOL)
-2.67
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.9
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.03
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.86
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5